Actinium Pharmaceuticals Story

Actinium Pharmaceuticals Inc -- USA Stock  

USD 0.41  0.05  13.89%

Macroaxis does not monitor all media channels or aggregates social signals for Actinium Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Actinium Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Actinium Pharmaceuticals. Check also Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance
Acquisition or disposition of Actinium Pharmaceuticals securities by Nitya Ray
Filed transaction by Actinium Pharmaceuticals officer. Acquisition or disposition under rule 16b-3

Actinium Pharmaceuticals Inc insider trading alert for acquisition or disposition of series b warrants by Nitya Ray, Executive VP, on March 8, 2018. This event was filed by Actinium Pharmaceuticals with SEC on 2018-03-08. Statement of changes in beneficial ownership - SEC Form 4. Nitya Ray is currently serves as executive vice president head - product development, manufacturing and supply chain of Actinium Pharmaceuticals

Story Momentum

This media report from MacroaxisInsider distributed on March 8, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 0.02% . The overall trading delta when the story was published against the current closing price is 1.19% .

Similar stores for Actinium Pharmaceuticals

PE to Consider Actinium Pharmaceuticals Incnews
Stocks Market CapFull coverage
3 days ago at 
Analysts See -0.10 EPS for Actinium Pharmaceuticals, Inc.
ReuropeEPS for Actinium Pharmaceuticals, Inc. Expected At -0.10 Weekly RegisterFull coverage
few days ago at 
Oversold Signal Stock Actinium Pharmaceuticals, Inc.
nasdaq News
Nasdaq ChronicleFull coverage
over a week ago at 
Hair-Raising Facts to Know Actinium Pharmaceuticals Inc
Alpha Beta StockFull coverage

Did you try this?

Run Fund Screener Now

Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
Hide  View All  NextLaunch Fund Screener

Working Capital

Working Capital Comparative Analysis
  Working Capital 
      Actinium Pharmaceuticals Comparables 
Actinium Pharmaceuticals is currently under evaluation in working capital category among related companies. Working Capital is measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is important indicator of the firm ability to continue its normal operations without additional debt obligations. .